المؤلفون: Ankarfeldt MZ; Copenhagen Phase IV Unit (Phase4CPH), Center for Clinical Research and Prevention, Copenhagen University Hospital Bispebjerg and Frederiksberg, Frederiksberg, Denmark., Søltoft-Jensen A; Copenhagen Phase IV Unit (Phase4CPH), Center for Clinical Research and Prevention, Copenhagen University Hospital Bispebjerg and Frederiksberg, Frederiksberg, Denmark., Salinas CA; Eli Lilly and Company, Indianapolis, Indiana, USA., Lupattelli A; Pharmacoepidemiology and Drug Safety Research Group, Department of Pharmacy, Faculty of Mathematics and Natural Sciences, University of Oslo, Oslo, Norway., Pukkala E; Health Sciences Unit, Faculty of Social Sciences, Tampere University, Tampere, Finland., Bolin K; Department of Economics. Centre for Health Governance, University of Gothenburg, Göteborg, Sweden., Smith S; MedEngine, Helsinki, Finland., Meyers KJ; Eli Lilly and Company, Indianapolis, Indiana, USA., Petersen J; Copenhagen Phase IV Unit (Phase4CPH), Center for Clinical Research and Prevention, Copenhagen University Hospital Bispebjerg and Frederiksberg, Frederiksberg, Denmark.; Section of Biostatistics, Department of Public Health, University of Copenhagen, Kobenhavn, Denmark., Jimenez-Solem E; Copenhagen Phase IV Unit (Phase4CPH), Center for Clinical Research and Prevention, Copenhagen University Hospital Bispebjerg and Frederiksberg, Frederiksberg, Denmark.; Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.; Department of Clinical Pharmacology, Copenhagen University Hospital Bispebjerg and Frederiksberg, Copenhagen, Denmark.

المصدر: Pharmacoepidemiology and drug safety [Pharmacoepidemiol Drug Saf] 2024 Sep; Vol. 33 (9), pp. e70010.

نوع المنشور: Journal Article; Observational Study

بيانات الدورية: Publisher: Wiley Country of Publication: England NLM ID: 9208369 Publication Model: Print Cited Medium: Internet ISSN: 1099-1557 (Electronic) Linking ISSN: 10538569 NLM ISO Abbreviation: Pharmacoepidemiol Drug Saf Subsets: MEDLINE

مواضيع طبية MeSH: Arthritis, Rheumatoid*/drug therapy , Purines*/adverse effects , Purines*/therapeutic use , Purines*/administration & dosage , Sulfonamides*/adverse effects , Sulfonamides*/therapeutic use , Sulfonamides*/administration & dosage , Azetidines*/therapeutic use , Azetidines*/adverse effects , Azetidines*/administration & dosage , Pyrazoles*/therapeutic use , Pyrazoles*/adverse effects , Antirheumatic Agents*/therapeutic use , Antirheumatic Agents*/adverse effects, Humans ; Female ; Middle Aged ; Adult ; Male ; Cohort Studies ; Young Adult ; Adolescent ; Pregnancy ; Scandinavian and Nordic Countries/epidemiology ; Registries ; Tuberculosis/epidemiology ; Tuberculosis/prevention & control ; Hyperlipidemias/drug therapy ; Hyperlipidemias/epidemiology ; Aged

المؤلفون: Li X; Department of Dermatology and Venerology, Shandong Provincial Hospital for Skin Diseases & Shandong Provincial Institute of Dermatology and Venerology, Shandong First Medical University & Shandong Academy of Medical Sciences, Huaiyin District, Jinan, Shandong, China., Liu G; Department of Dermatology and Venerology, Shandong Provincial Hospital for Skin Diseases & Shandong Provincial Institute of Dermatology and Venerology, Shandong First Medical University & Shandong Academy of Medical Sciences, Huaiyin District, Jinan, Shandong, China., Chen S; Department of Dermatology and Venerology, Shandong Provincial Hospital for Skin Diseases & Shandong Provincial Institute of Dermatology and Venerology, Shandong First Medical University & Shandong Academy of Medical Sciences, Huaiyin District, Jinan, Shandong, China., Liu Y; Department of Dermatology and Venerology, Shandong Provincial Hospital for Skin Diseases & Shandong Provincial Institute of Dermatology and Venerology, Shandong First Medical University & Shandong Academy of Medical Sciences, Huaiyin District, Jinan, Shandong, China.

المصدر: Indian journal of dermatology, venereology and leprology [Indian J Dermatol Venereol Leprol] 2024 Sep-Oct; Vol. 90 (5), pp. 668-670.

نوع المنشور: Letter; Case Reports

بيانات الدورية: Publisher: Scientific Scholar on behalf of Indian Association of Dermatologists, Venereologists & Leprologists Country of Publication: United States NLM ID: 7701852 Publication Model: Print Cited Medium: Internet ISSN: 0973-3922 (Electronic) Linking ISSN: 03786323 NLM ISO Abbreviation: Indian J Dermatol Venereol Leprol Subsets: MEDLINE

مواضيع طبية MeSH: Sulfonamides*/adverse effects , Sulfonamides*/therapeutic use , Azetidines*/adverse effects , Azetidines*/therapeutic use , Dermatitis, Atopic*/drug therapy , Pyrazoles*/adverse effects , Pyrazoles*/therapeutic use , Purines*/adverse effects , Purines*/therapeutic use , Psoriasis*/drug therapy , Psoriasis*/complications, Humans ; Treatment Outcome ; Male ; Female ; Adult

المؤلفون: Reviron R; CHU Réunion, Service des Maladies Infectieuses - Dermatologie, Saint Pierre, La Réunion, France., Joly E; CHU Réunion, Service des Maladies Infectieuses - Dermatologie, Saint Pierre, La Réunion, France., Bertolotti A; CHU Réunion, Service des Maladies Infectieuses - Dermatologie, Saint Pierre, La Réunion, France; Inserm CIC1410, CHU Réunion, Saint Pierre, La Réunion, France. Electronic address: antoine_bertolotti@yahoo.fr.

المصدر: Annales de dermatologie et de venereologie [Ann Dermatol Venereol] 2024 Sep; Vol. 151 (3), pp. 103300. Date of Electronic Publication: 2024 Jul 17.

نوع المنشور: Letter; Case Reports

بيانات الدورية: Publisher: Masson Country of Publication: France NLM ID: 7702013 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 0151-9638 (Print) Linking ISSN: 01519638 NLM ISO Abbreviation: Ann Dermatol Venereol Subsets: MEDLINE

مواضيع طبية MeSH: Azetidines*/therapeutic use , Azetidines*/administration & dosage , Sulfonamides*/administration & dosage , Sulfonamides*/therapeutic use , Vitiligo*/therapy , Vitiligo*/drug therapy , Purines*/administration & dosage , Purines*/therapeutic use , Pyrazoles*/therapeutic use , Pyrazoles*/administration & dosage, Humans ; Male ; Female ; Adult ; Administration, Oral ; Middle Aged ; Combined Modality Therapy ; Phototherapy

المؤلفون: Covert LT; Department of Pediatrics, Duke University Health System, Durham, NC, USA., Prinz JA; Sequencing and Genomics Technologies Core Facility, School of Medicine, Duke University, Durham, NC, USA., Swain-Lenz D; Sequencing and Genomics Technologies Core Facility, School of Medicine, Duke University, Durham, NC, USA.; Department of Molecular Genetics and Microbiology, School of Medicine, Duke University, Durham, NC, USA., Dvergsten J; Department of Pediatrics, Duke University Health System, Durham, NC, USA., Truskey GA; Department of Biomedical Engineering, Duke University, Durham, NC, USA.

المصدر: Rheumatology (Oxford, England) [Rheumatology (Oxford)] 2024 Sep 01; Vol. 63 (SI2), pp. SI240-SI248.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Oxford University Press Country of Publication: England NLM ID: 100883501 Publication Model: Print Cited Medium: Internet ISSN: 1462-0332 (Electronic) Linking ISSN: 14620324 NLM ISO Abbreviation: Rheumatology (Oxford) Subsets: MEDLINE

مواضيع طبية MeSH: Dermatomyositis*/genetics , Dermatomyositis*/drug therapy , Janus Kinase Inhibitors*/therapeutic use , Janus Kinase Inhibitors*/pharmacology , Azetidines*/pharmacology , Azetidines*/therapeutic use , Interferon Type I*/metabolism, Humans ; Child ; Sulfonamides/pharmacology ; Sulfonamides/therapeutic use ; Muscle, Skeletal/metabolism ; Muscle, Skeletal/drug effects ; Pyrimidines/therapeutic use ; Pyrimidines/pharmacology ; Pyrazoles/therapeutic use ; Pyrazoles/pharmacology ; Purines/pharmacology ; Purines/therapeutic use ; Piperidines/therapeutic use ; Piperidines/pharmacology ; Myoblasts/drug effects ; Myoblasts/metabolism ; Interferon-alpha

المؤلفون: Zhao X; Department of Dermatology, Beijing Children's Hospital, Capital Medical University, National Center for Children's Health, Xicheng, Beijing, China., Miao C; Department of Dermatology, Beijing Children's Hospital, Capital Medical University, National Center for Children's Health, Xicheng, Beijing, China., Chen Y; Department of Dermatology, Beijing Children's Hospital, Capital Medical University, National Center for Children's Health, Xicheng, Beijing, China., Xiang X; Department of Dermatology, Beijing Children's Hospital, Capital Medical University, National Center for Children's Health, Xicheng, Beijing, China., Liu Y; Department of Dermatology, Beijing Children's Hospital, Capital Medical University, National Center for Children's Health, Xicheng, Beijing, China., Zhaoyang W; Department of Dermatology, Beijing Children's Hospital, Capital Medical University, National Center for Children's Health, Xicheng, Beijing, China., Xu Z; Department of Dermatology, Beijing Children's Hospital, Capital Medical University, National Center for Children's Health, Xicheng, Beijing, China.

المصدر: Indian journal of dermatology, venereology and leprology [Indian J Dermatol Venereol Leprol] 2024 Sep-Oct; Vol. 90 (5), pp. 703.

نوع المنشور: Case Reports; Letter

بيانات الدورية: Publisher: Scientific Scholar on behalf of Indian Association of Dermatologists, Venereologists & Leprologists Country of Publication: United States NLM ID: 7701852 Publication Model: Print Cited Medium: Internet ISSN: 0973-3922 (Electronic) Linking ISSN: 03786323 NLM ISO Abbreviation: Indian J Dermatol Venereol Leprol Subsets: MEDLINE

مواضيع طبية MeSH: Pyrazoles*/adverse effects , Pyrazoles*/therapeutic use , Hydroxychloroquine*/therapeutic use , Hydroxychloroquine*/adverse effects , Sulfonamides*/therapeutic use , Sulfonamides*/adverse effects , Azetidines*/therapeutic use , Azetidines*/adverse effects , Purines*/adverse effects , Purines*/therapeutic use, Humans ; Male ; Lipodystrophy/drug therapy ; Lipodystrophy/diagnosis ; Skin Ulcer/drug therapy ; Skin Ulcer/diagnosis ; Drug Therapy, Combination

المؤلفون: You SH; Department of Global Innovative Drugs, The Graduate School of Chung-Ang University, Chung-Ang University, Seoul, Republic of Korea., Baek MS; Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, Chung-Ang University Hospital, Chung-Ang University College of Medicine, Seoul, Republic of Korea., Kim TW; Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, Chung-Ang University Hospital, Chung-Ang University College of Medicine, Seoul, Republic of Korea., Jung SY; Department of Global Innovative Drugs, The Graduate School of Chung-Ang University, Chung-Ang University, Seoul, Republic of Korea. jsyoung@cau.ac.kr.; College of Pharmacy, Chung-Ang University, Seoul, Republic of Korea. jsyoung@cau.ac.kr., Kim WY; Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, Chung-Ang University Hospital, Chung-Ang University College of Medicine, Seoul, Republic of Korea. wykim81@cau.ac.kr.

المصدر: Critical care (London, England) [Crit Care] 2024 Aug 29; Vol. 28 (1), pp. 282. Date of Electronic Publication: 2024 Aug 29.

نوع المنشور: Letter; Comparative Study

بيانات الدورية: Publisher: BioMed Central Ltd Country of Publication: England NLM ID: 9801902 Publication Model: Electronic Cited Medium: Internet ISSN: 1466-609X (Electronic) Linking ISSN: 13648535 NLM ISO Abbreviation: Crit Care Subsets: MEDLINE

مواضيع طبية MeSH: Respiration, Artificial* , Antibodies, Monoclonal, Humanized*/therapeutic use , COVID-19 Drug Treatment* , Pyrazoles*/therapeutic use , Azetidines*/therapeutic use , Azetidines*/administration & dosage, Humans ; Male ; Female ; Cohort Studies ; Middle Aged ; Aged ; Purines/therapeutic use ; Sulfonamides/therapeutic use ; COVID-19

المؤلفون: Cetin Gedik K; Translational Autoinflammatory Diseases Section, LCIM, NIAID, National Institutes of Health, Bethesda, Maryland, USA raphaela.goldbach-mansky@nih.gov cetingedikk@upmc.edu.; Division of Pediatric Rheumatology, Children's Hospital of Pittsburgh of University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania, USA., Ortega-Villa AM; Biostatistics Research Branch, Division of Clinical Research, NIAID, National Institutes of Health, Bethesda, Maryland, USA., Materne G; Translational Autoinflammatory Diseases Section, LCIM, NIAID, National Institutes of Health, Bethesda, Maryland, USA., Rastegar A; Translational Autoinflammatory Diseases Section, LCIM, NIAID, National Institutes of Health, Bethesda, Maryland, USA., Montealegre Sanchez GA; Division of Clinical Research, NIAID, National Institutes of Health, Bethesda, Maryland, USA., Reinhardt A; Boys Town National Research Hospital, Omaha, Nebraska, USA., Brogan PA; University College London Great Ormond Street Institute of Child Health, London, UK.; Great Ormond Street Hospital for Children NHS Foundation Trust, London, UK., Berkun Y; Department of Pediatrics, Hadassah Hebrew University Medical Center, Jerusalem, Israel., Murias S; Hospital Universitario La Paz, Madrid, Spain., Robles M; Eskenazi Health Center, Indianapolis, Indiana, USA., Schalm S; Rheumatologie im Zentrum, Munich, Germany., de Jesus AA; Translational Autoinflammatory Diseases Section, LCIM, NIAID, National Institutes of Health, Bethesda, Maryland, USA., Goldbach-Mansky R; Translational Autoinflammatory Diseases Section, LCIM, NIAID, National Institutes of Health, Bethesda, Maryland, USA raphaela.goldbach-mansky@nih.gov cetingedikk@upmc.edu.

المصدر: Annals of the rheumatic diseases [Ann Rheum Dis] 2024 Aug 27; Vol. 83 (9), pp. 1181-1188. Date of Electronic Publication: 2024 Aug 27.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: BMJ Country of Publication: England NLM ID: 0372355 Publication Model: Electronic Cited Medium: Internet ISSN: 1468-2060 (Electronic) Linking ISSN: 00034967 NLM ISO Abbreviation: Ann Rheum Dis Subsets: MEDLINE

مواضيع طبية MeSH: Purines*/administration & dosage , Pyrazoles*/administration & dosage , Pyrazoles*/therapeutic use , Sulfonamides*/administration & dosage , Sulfonamides*/therapeutic use , Azetidines*/administration & dosage , Azetidines*/therapeutic use , Drug Tapering*, Humans ; Female ; Male ; Adult ; Middle Aged ; Retrospective Studies ; Symptom Flare Up ; Lipodystrophy ; Janus Kinase Inhibitors/administration & dosage ; Janus Kinase Inhibitors/therapeutic use ; Hereditary Autoinflammatory Diseases/drug therapy ; Hereditary Autoinflammatory Diseases/diagnosis ; Dose-Response Relationship, Drug

المؤلفون: Ono D; Division of Infectious Diseases, Department of Medicine, Case Western Reserve University School of Medicine, Cleveland, Ohio, USA.; Department of Molecular Biology and Microbiology, Case Western Reserve University School of Medicine, Cleveland, Ohio, USA.; Research Service, Louis Stokes Cleveland Department of Veterans Affairs Medical Center, Cleveland, Ohio, USA., Cmolik A; Research Service, Louis Stokes Cleveland Department of Veterans Affairs Medical Center, Cleveland, Ohio, USA., Bethel CR; Research Service, Louis Stokes Cleveland Department of Veterans Affairs Medical Center, Cleveland, Ohio, USA., Ishii Y; The Center for Planetary Health and Innovation Science (PHIS), The IDEC Institute, Hiroshima University, Hiroshima, Japan., Drusin SI; Instituto de Química Rosario (IQUIR, CONICET-UNR), Rosario, Santa Fe, Argentina.; Facultad de Ciencias Bioquímicas y Farmacéuticas, Universidad Nacional de Rosario, Rosario, Santa Fe, Argentina., Moreno DM; Instituto de Química Rosario (IQUIR, CONICET-UNR), Rosario, Santa Fe, Argentina.; Facultad de Ciencias Bioquímicas y Farmacéuticas, Universidad Nacional de Rosario, Rosario, Santa Fe, Argentina., Vila AJ; Facultad de Ciencias Bioquímicas y Farmacéuticas, Universidad Nacional de Rosario, Rosario, Santa Fe, Argentina.; Laboratorio de Metaloproteínas, Instituto de Biología Molecular y Celular de Rosario (CONICET IBR -UNR), Rosario, Santa Fe, Argentina.; CWRU-Cleveland VAMC Center for Antimicrobial Resistance and Epidemiology (Case VA CARES), Cleveland, Ohio, USA., Bonomo RA; Division of Infectious Diseases, Department of Medicine, Case Western Reserve University School of Medicine, Cleveland, Ohio, USA.; Department of Molecular Biology and Microbiology, Case Western Reserve University School of Medicine, Cleveland, Ohio, USA.; Research Service, Louis Stokes Cleveland Department of Veterans Affairs Medical Center, Cleveland, Ohio, USA.; CWRU-Cleveland VAMC Center for Antimicrobial Resistance and Epidemiology (Case VA CARES), Cleveland, Ohio, USA.; Departments of Pharmacology, Biochemistry, Proteomics and Bioinformatics, Case Western Reserve University School of Medicine, Cleveland, Ohio, USA.; Clinician Scientist Investigator, Louis Stokes Cleveland Department of Veterans Affairs Medical Center, Cleveland, Ohio, USA., Mojica MF; Department of Molecular Biology and Microbiology, Case Western Reserve University School of Medicine, Cleveland, Ohio, USA.; Research Service, Louis Stokes Cleveland Department of Veterans Affairs Medical Center, Cleveland, Ohio, USA.; CWRU-Cleveland VAMC Center for Antimicrobial Resistance and Epidemiology (Case VA CARES), Cleveland, Ohio, USA.; Grupo de Investigación en Resistencia Antimicrobiana y Epidemiología Hospitalaria, Universidad El Bosque, Bogotá, Colombia.

المصدر: Antimicrobial agents and chemotherapy [Antimicrob Agents Chemother] 2024 Aug 07; Vol. 68 (8), pp. e0068724. Date of Electronic Publication: 2024 Jul 18.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: American Society for Microbiology Country of Publication: United States NLM ID: 0315061 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1098-6596 (Electronic) Linking ISSN: 00664804 NLM ISO Abbreviation: Antimicrob Agents Chemother Subsets: MEDLINE

مواضيع طبية MeSH: beta-Lactamases*/genetics , beta-Lactamases*/metabolism , Microbial Sensitivity Tests* , Carbapenems*/pharmacology , Anti-Bacterial Agents*/pharmacology , Thiazoles*/pharmacology , Thiazoles*/chemistry , Catalytic Domain* , Azetidines*/pharmacology , Azetidines*/chemistry , Escherichia coli*/drug effects , Escherichia coli*/genetics, Molecular Dynamics Simulation ; Meropenem/pharmacology ; Meropenem/chemistry ; Structure-Activity Relationship

المؤلفون: Chen PK; Rheumatology and Immunology Center, China Medical University Hospital, No. 2, Yude Road, Taichung, 40447, Taiwan.; College of Medicine, China Medical University, Taichung, Taiwan., Chang SH; Rheumatology and Immunology Center, China Medical University Hospital, No. 2, Yude Road, Taichung, 40447, Taiwan.; College of Medicine, China Medical University, Taichung, Taiwan.; Ph.D. Program in Translational Medicine and Rong Hsing Research Center for Translational Medicine, National Chung Hsing University, Taichung, Taiwan., Chen YM; Division of Translational Medicine, Department of Medical Research, Taichung Veterans General Hospital, Taichung, Taiwan.; School of Medicine, National Yang-Ming Chiao Tung University, Taipei, Taiwan.; Department of Post-Baccalaureate Medicine, College of Medicine, National Chung Hsing University, Taichung, Taiwan., Chen HH; Department of Post-Baccalaureate Medicine, College of Medicine, National Chung Hsing University, Taichung, Taiwan.; Department of Industrial Engineering and Enterprise Information, Tunghai University, Taichung, Taiwan.; Big Data Center, National Chung Hsing University, Taichung, Taiwan., Huang PH; Rheumatology and Immunology Center, China Medical University Hospital, No. 2, Yude Road, Taichung, 40447, Taiwan.; College of Medicine, China Medical University, Taichung, Taiwan., Huang CC; Rheumatology and Immunology Center, China Medical University Hospital, No. 2, Yude Road, Taichung, 40447, Taiwan.; College of Medicine, China Medical University, Taichung, Taiwan., Yeo KJ; Rheumatology and Immunology Center, China Medical University Hospital, No. 2, Yude Road, Taichung, 40447, Taiwan.; College of Medicine, China Medical University, Taichung, Taiwan., Lan JL; Rheumatology and Immunology Center, China Medical University Hospital, No. 2, Yude Road, Taichung, 40447, Taiwan.; College of Medicine, China Medical University, Taichung, Taiwan., Chen DY; Rheumatology and Immunology Center, China Medical University Hospital, No. 2, Yude Road, Taichung, 40447, Taiwan. dychen1957@gmail.com.; College of Medicine, China Medical University, Taichung, Taiwan. dychen1957@gmail.com.; Institute of Medicine, Chung Shan Medical University, Taichung, Taiwan. dychen1957@gmail.com.

المصدر: Clinical rheumatology [Clin Rheumatol] 2024 Aug; Vol. 43 (8), pp. 2503-2511. Date of Electronic Publication: 2024 Jul 02.

نوع المنشور: Journal Article; Observational Study

بيانات الدورية: Publisher: Springer Country of Publication: Germany NLM ID: 8211469 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1434-9949 (Electronic) Linking ISSN: 07703198 NLM ISO Abbreviation: Clin Rheumatol Subsets: MEDLINE

مواضيع طبية MeSH: Arthritis, Rheumatoid*/drug therapy , Herpes Zoster*/chemically induced , Herpes Zoster*/prevention & control , Herpes Zoster*/epidemiology , Janus Kinase Inhibitors*/adverse effects , Janus Kinase Inhibitors*/therapeutic use , Adrenal Cortex Hormones*/administration & dosage , Adrenal Cortex Hormones*/adverse effects , Adrenal Cortex Hormones*/therapeutic use , Azetidines*/adverse effects , Azetidines*/therapeutic use, Humans ; Retrospective Studies ; Male ; Female ; Middle Aged ; Aged ; Risk Factors ; Sulfonamides/adverse effects ; Sulfonamides/administration & dosage ; Sulfonamides/therapeutic use ; Piperidines/adverse effects ; Piperidines/therapeutic use ; Piperidines/administration & dosage ; Incidence ; Pyrazoles/adverse effects ; Purines/adverse effects ; Pyrimidines/adverse effects ; Heterocyclic Compounds, 3-Ring/adverse effects ; Heterocyclic Compounds, 3-Ring/therapeutic use ; Heterocyclic Compounds, 3-Ring/administration & dosage ; COVID-19/epidemiology ; Adult ; SARS-CoV-2 ; Antirheumatic Agents/adverse effects ; Antirheumatic Agents/therapeutic use

المؤلفون: Hendek HH; Department of Neurology, Ruhr-University Bochum, St. Josef-Hospital, Gudrunstr. 56, 44791, Bochum, Germany., Blusch A; Department of Neurology, Ruhr-University Bochum, St. Josef-Hospital, Gudrunstr. 56, 44791, Bochum, Germany., Heitmann N; Department of Neurology, Ruhr-University Bochum, St. Josef-Hospital, Gudrunstr. 56, 44791, Bochum, Germany., Oberhagemann S; Department of Neurology, Ruhr-University Bochum, St. Josef-Hospital, Gudrunstr. 56, 44791, Bochum, Germany., Demir S; Department of Neurology, Ruhr-University Bochum, St. Josef-Hospital, Gudrunstr. 56, 44791, Bochum, Germany., Pedreiturria X; Department of Neurology, Ruhr-University Bochum, St. Josef-Hospital, Gudrunstr. 56, 44791, Bochum, Germany., Gold R; Department of Neurology, Ruhr-University Bochum, St. Josef-Hospital, Gudrunstr. 56, 44791, Bochum, Germany., Faissner S; Department of Neurology, Ruhr-University Bochum, St. Josef-Hospital, Gudrunstr. 56, 44791, Bochum, Germany. simon.faissner@rub.de.

المصدر: Scientific reports [Sci Rep] 2024 Aug 01; Vol. 14 (1), pp. 17823. Date of Electronic Publication: 2024 Aug 01.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Nature Publishing Group Country of Publication: England NLM ID: 101563288 Publication Model: Electronic Cited Medium: Internet ISSN: 2045-2322 (Electronic) Linking ISSN: 20452322 NLM ISO Abbreviation: Sci Rep Subsets: MEDLINE

مواضيع طبية MeSH: Azetidines*/pharmacology , Azetidines*/therapeutic use , Benzyl Compounds*/pharmacology , Benzyl Compounds*/therapeutic use , Brain-Derived Neurotrophic Factor*/metabolism , Encephalomyelitis, Autoimmune, Experimental*/drug therapy , Encephalomyelitis, Autoimmune, Experimental*/metabolism , Encephalomyelitis, Autoimmune, Experimental*/pathology , Multiple Sclerosis*/drug therapy , Multiple Sclerosis*/metabolism, Animals ; Female ; Mice ; Disease Models, Animal ; Mice, Inbred C57BL ; Mice, Knockout ; Sphingosine 1 Phosphate Receptor Modulators/pharmacology ; Sphingosine 1 Phosphate Receptor Modulators/therapeutic use ; Spinal Cord/metabolism ; Spinal Cord/drug effects ; Spinal Cord/pathology